Zonisamide Capsule
NDC Package 29300-430-01
Package Information
Zonisamide capsules is zonisamide is used with other medications to prevent and control seizures (epilepsy). This formulation utilizes a capsule delivery system. Marketed by Unichem Pharmaceuticals (usa), Inc., this product is identified by NDC 29300-430 and is authorized under FDA application ANDA214492.
Identification & Billing
- RxCUI: 314285 - zonisamide 100 MG Oral Capsule
- RxCUI: 403966 - zonisamide 25 MG Oral Capsule
- RxCUI: 403967 - zonisamide 50 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 29300 - Unichem Pharmaceuticals (usa), Inc.
- 29300-430 - Zonisamide
- 29300-430-01 - 100 CAPSULE in 1 BOTTLE
- 29300-430 - Zonisamide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (29300-430). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 29300-430-01 identifies a specific commercial package of 100 capsule in 1 bottle of Zonisamide, a human prescription drug labeled by Unichem Pharmaceuticals (usa), Inc.. This capsule is formulated for oral use and contains zonisamide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Unichem Pharmaceuticals (usa), Inc. on July 09, 2021. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Zonisamide is used with other medications to prevent and control seizures (epilepsy). Zonisamide is a sulfonamide anticonvulsant and a carbonic anhydrase inhibitor. It is unknown how zonisamide works to prevent seizures.
How is this Unichem Pharmaceuticals (usa), Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 29300043001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.